Arrowstreet Capital’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-360,565
Closed -$6.57M 1834
2025
Q2
$6.57M Sell
360,565
-755,494
-68% -$15.4M ﹤0.01% 1051
2025
Q1
$22.1M Sell
1,116,059
-1,646,641
-60% -$28.5M 0.02% 570
2024
Q4
$47.4M Buy
2,762,700
+1,013,456
+58% +$19.1M 0.04% 389
2024
Q3
$35M Buy
1,749,244
+1,084,186
+163% +$16.9M 0.03% 409
2024
Q2
$7.43M Buy
665,058
+599,100
+908% +$5.03M 0.01% 727
2024
Q1
$435K Buy
+65,958
New +$361K ﹤0.01% 1468
2018
Q4
Sell
-16,400
Closed -$102K 1325
2018
Q3
$102K Sell
16,400
-7,700
-32% -$44.3K ﹤0.01% 1047
2018
Q2
$108K Buy
+24,100
New +$120K ﹤0.01% 1032

Other funds holding ADMA